Kun‐Huei Yeh

Closest collaborators

The 13 strongest of 13 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

1. Sung‐Hsin Kuo · 8 shared papers, 2016–2026 · strength 1.16
   • Paper Improved survival with adding-on strategy after failure of nanoliposomal irinotecan plus 5-fluorouracil and leucovorin … DOI 10.1016/j.jfma.2025.02.035↗
   • Paper Adding-on nivolumab to chemotherapy-stabilized patients is associated with improved survival in advanced pancreatic duc… DOI 10.1007/s00262-024-03821-3↗
   • Paper Contribution of nuclear BCL10 expression to tumor progression and poor prognosis of advanced and/or metastatic pancreat… DOI 10.1186/s12935-021-02143-z↗
2. Ann‐Lii Cheng · 7 shared papers, 2016–2024 · strength 0.84
   • Paper Adding-on nivolumab to chemotherapy-stabilized patients is associated with improved survival in advanced pancreatic duc… DOI 10.1007/s00262-024-03821-3↗
   • Paper Contribution of nuclear BCL10 expression to tumor progression and poor prognosis of advanced and/or metastatic pancreat… DOI 10.1186/s12935-021-02143-z↗
   • Paper Negative prognostic implications of splenomegaly in nivolumab-treated advanced or recurrent pancreatic adenocarcinoma. DOI 10.1080/2162402x.2021.1973710↗
3. Shih‐Hung Yang · 7 shared papers, 2016–2024 · strength 0.84
   • Paper Adding-on nivolumab to chemotherapy-stabilized patients is associated with improved survival in advanced pancreatic duc… DOI 10.1007/s00262-024-03821-3↗
   • Paper Contribution of nuclear BCL10 expression to tumor progression and poor prognosis of advanced and/or metastatic pancreat… DOI 10.1186/s12935-021-02143-z↗
   • Paper Negative prognostic implications of splenomegaly in nivolumab-treated advanced or recurrent pancreatic adenocarcinoma. DOI 10.1080/2162402x.2021.1973710↗
4. Yu‐Wen Tien · 6 shared papers, 2016–2024 · strength 0.75
   • Paper Adding-on nivolumab to chemotherapy-stabilized patients is associated with improved survival in advanced pancreatic duc… DOI 10.1007/s00262-024-03821-3↗
   • Paper Contribution of nuclear BCL10 expression to tumor progression and poor prognosis of advanced and/or metastatic pancreat… DOI 10.1186/s12935-021-02143-z↗
   • Paper Negative prognostic implications of splenomegaly in nivolumab-treated advanced or recurrent pancreatic adenocarcinoma. DOI 10.1080/2162402x.2021.1973710↗
5. Shih-Hung Yang · 1 shared paper, 2026 · strength 0.63
   • Paper Authors' reply to "On the definition of treatment failure after nanoliposomal irinotecan-based therapy in metastatic pa… DOI 10.1016/j.jfma.2026.04.076↗
6. Yan‐Shen Shan · 2 shared papers, 2024–2026 · strength 0.53
   • Paper Improved survival with adding-on strategy after failure of nanoliposomal irinotecan plus 5-fluorouracil and leucovorin … DOI 10.1016/j.jfma.2025.02.035↗
   • Paper Adding-on nivolumab to chemotherapy-stabilized patients is associated with improved survival in advanced pancreatic duc… DOI 10.1007/s00262-024-03821-3↗
7. Bang‐Bin Chen · 2 shared papers, 2021–2024 · strength 0.35
   • Paper Adding-on nivolumab to chemotherapy-stabilized patients is associated with improved survival in advanced pancreatic duc… DOI 10.1007/s00262-024-03821-3↗
   • Paper Negative prognostic implications of splenomegaly in nivolumab-treated advanced or recurrent pancreatic adenocarcinoma. DOI 10.1080/2162402x.2021.1973710↗
8. Chien‐Jui Huang · 1 shared paper, 2026 · strength 0.32
   • Paper Improved survival with adding-on strategy after failure of nanoliposomal irinotecan plus 5-fluorouracil and leucovorin … DOI 10.1016/j.jfma.2025.02.035↗
9. Shih‐Hung Yang · 1 shared paper, 2026 · strength 0.32
   • Paper Improved survival with adding-on strategy after failure of nanoliposomal irinotecan plus 5-fluorouracil and leucovorin … DOI 10.1016/j.jfma.2025.02.035↗
10. Jhe‐Cyuan Guo · 3 shared papers, 2016–2020 · strength 0.25
    • Paper Low-dose nab-paclitaxel-based combination chemotherapy in heavily pretreated pancreatic cancer patients. DOI 10.1016/j.jfma.2019.01.015↗
    • Paper Association of radiotherapy with favorable prognosis in daily clinical practice for treatment of locally advanced and m… DOI 10.1111/jgh.13395↗
    • Paper Perspectives on the combination of radiotherapy and targeted therapy with DNA repair inhibitors in the treatment of pan… DOI 10.3748/wjg.v22.i32.7275↗
11. Ting‐Chun Kuo · 2 shared papers, 2016–2021 · strength 0.19
    • Paper Negative prognostic implications of splenomegaly in nivolumab-treated advanced or recurrent pancreatic adenocarcinoma. DOI 10.1080/2162402x.2021.1973710↗
    • Paper Perspectives on the combination of radiotherapy and targeted therapy with DNA repair inhibitors in the treatment of pan… DOI 10.3748/wjg.v22.i32.7275↗
12. Li‐Yuan Bai · 1 shared paper, 2021 · strength 0.13
    • Paper Negative prognostic implications of splenomegaly in nivolumab-treated advanced or recurrent pancreatic adenocarcinoma. DOI 10.1080/2162402x.2021.1973710↗
13. Hsu Wu · 1 shared paper, 2016 · strength 0.06
    • Paper Perspectives on the combination of radiotherapy and targeted therapy with DNA repair inhibitors in the treatment of pan… DOI 10.3748/wjg.v22.i32.7275↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.